Fisher & Paykel Healthcare Corporation Limited announced that F&P Evora™, a nasal mask for the treatment of obstructive sleep apnea (OSA) has received regulatory clearance for use in the United States.
F&P Evora is a compact nasal mask that sits comfortably under the nose. The mask features CapFit™ headgear, which is designed for patients to put on like a baseball cap in one simple and intuitive movement. In a clinical trial, 98 percent of participants described F&P Evora as “simple to take off and put on in the dark,” and 95 percent of respiratory therapists found the mask “simple to fit.”
Evora also features the next generation of Dynamic Support Technology comprising of a ‘floating’ seal, which sits inside stability wings. This technology allows for freedom of movement during sleep while keeping the mask comfortably in place.
“Evora offers OSA patients the performance benefits of a nasal mask, with the streamlined design and minimalism of a nasal pillow mask,” said Lewis Gradon, Managing Director and CEO of Fisher & Paykel Healthcare. “This is a revolutionary product that makes fitting the mask and educating the patient much easier. We’re excited to bring it to market.”
For more information, click here.
1. 20 out of 21 respiratory therapists rated the simplicity of the Evora Nasal mask as very simple or simple to fit. Internal validation study conducted with 21 respiratory therapists in United States of America 2019. 2. 43 out of 44 participants were able to put on and take off the Evora Nasal mask once fitted, in the dark. Internal validation study conducted with 44 participants in United States of America 2019.